Oculis

1 follower

‌

Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back-and front-of-the-eye in order to improve the sight and the lives of patients worldwide.

Industries

Biotechnology

Headquarters

Lausanne, Switzerland

Employees

11-50

Links

Org chart

Riad Sherif

Chief Executive Officer

Riad Sherif

Collapse

Sylvia Cheung

Chief Financial Officer

David Jacobs

Chief Development Officer

Páll Ragnar Jóhannesson

Chief Strategy Officer

Rebecca Weil

Chief Commercial Officer

Einar Stefansson

Co-Founder

Gudrun Bachmann

Chief Technology Officer

Louie Anne Gauthier

VP of Strategic Marketing and& Business Development & Licensing

Kate Allman

Vice President, Clinical Operations

Snehal Shah

President, Research & Development

Sharon Klier

Svp, Chief Development Officer

Teams

+10

Scientific Advisors and Research Scientists

13 members

Leadership Team

6 members

Financial Management and Analysis

6 members

Clinical Operations and Development

4 members

Offices

Similar companies

Lonza

37 followers

Roche

283 followers

Synthekine

3 followers

Caribou Biosciences

2 followers

Vera Therapeutics

2 followers

Neogene Therapeutics

2 followers

Kyverna Therapeutics

7 followers

Day One Biopharmaceuticals

1 follower

Isotopen Technologien München

1 follower

Aura Biosciences

1 follower

CG Oncology

1 follower

Explore companies